Diagnostic kit maker Meridian Bioscience will be acquired by South Korean firms SD Biosensor and PE firm SJL Partners, accelerating entry into US market.

The market for new company creation in the biopharma sector remains healthy and poised to continue fostering the establishment of start-ups, based on a new In Vivo study of the strong initial investments that pharma and biotech companies receive.

The agency says the diagnostics could produce inaccurate results, which may delay proper treatment and further the spread of COVID-19.

Less invasive transcatheter techniques will increasingly displace older, riskier open-heart procedures in the treatment of heart valve disease, according to a new Meddevicetracker report. By 2021, transcatheter systems will account for 76% of the global market for heart valve disease treatment products, with the US retaining its current dominant position in this sector.